Established in 2009, Novo Nordisk Research Center Seattle, Inc. (NNRCSI) is focused on early discovery projects within the diabetes and obesity areas. Our scientists apply cutting edge technologies to bring molecules to market. Right now, that means identifying protein-based therapies for obesity and prevention of diabetes, and diabetes treatment as well as research on the next generation of medical devices.
We are committed to making a difference in Seattle through support for local organizations and partnerships with the Seattle biotech and academic communities. Recently, NNRCSI employees participated in Beat the Bridge, a local fundraising event supporting type-1 diabetes research.
In the Community
NNRCSI is dedicated to environmental awareness and health, and we place emphasis on alternative means of transportation such as bicycling. Our company has received multiple awards from the Puget Sound Business Journal and the League of American Bicyclists for being a “bicycle-friendly” business. We also focus efforts toward recycling and composting, aligning with the city of Seattle’s initiatives for a cleaner environment.